GALAKATOS NICHOLAS
Insider CIK 1252522 · ACHN 10% owner · GMED · PTLA Director · KBIO 10% owner · AERI 10% owner · SOMX 10% owner · TLOG 10% owner · NSTG Director, 10% owner · HAIR 10% owner · OPHT Director, 10% owner · RDUS 10% owner · CATB Director, 10% owner · OXFD 10% owner · FTSV 10% owner · ETTX Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2019-06-19 | 2019-06-21 | 7,500 | — | $0 | 7,500 | SEC↗ |
| NSTG NanoString Technologies In | A Award deriv | 2019-03-25 | 2019-03-27 | 4,410 | — | $0 | 4,410 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | A Award deriv | 2019-01-18 | 2019-01-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 6,702,213 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 8,552,024 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 7,500,000 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 323,341 | — | $0 | 685,170 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 361,829 | — | $0 | 361,829 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | P Buy | 2018-09-28 | 2018-10-02 | 453,395 | $15.00 | $6.80M | 1,623,405 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 412,583 | — | $0 | 1,170,010 | SEC↗ |
| NSTG NanoString Technologies In | X Exercise deriv | 2018-09-17 | 2018-09-19 | 162,408 | — | $0 | 0 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2018-09-17 | 2018-09-19 | 85,823 | $15.99 | $1.37M | 4,036,025 | SEC↗ |
| NSTG NanoString Technologies In | X Exercise | 2018-09-17 | 2018-09-19 | 162,408 | $8.45 | $1.37M | 4,121,848 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 755,780 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 938,489 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 1,922,682 | — | $0 | 0 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 1,922,682 | — | $0 | 3,616,951 | SEC↗ |
| FTSV Forty Seven, Inc. | P Buy | 2018-07-02 | 2018-07-02 | 200,000 | $16.00 | $3.20M | 3,816,951 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 938,489 | — | $0 | 938,489 | SEC↗ |
| FTSV Forty Seven, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 755,780 | — | $0 | 1,694,269 | SEC↗ |
| NSTG NanoString Technologies In | A Award deriv | 2018-01-01 | 2018-01-03 | 10,168 | — | $0 | 10,168 | SEC↗ |
| HAIR Restoration Robotics Inc | C Conversion deriv | 2017-10-16 | 2017-10-17 | 3,389,105 | — | $0 | 0 | SEC↗ |
| HAIR Restoration Robotics Inc | C Conversion deriv | 2017-10-16 | 2017-10-17 | 0 | — | $0 | 0 | SEC↗ |
| HAIR Restoration Robotics Inc | C Conversion | 2017-10-16 | 2017-10-17 | 180,881 | $7.00 | $1.27M | 3,569,986 | SEC↗ |
| HAIR Restoration Robotics Inc | C Conversion | 2017-10-16 | 2017-10-17 | 3,389,105 | — | $0 | 3,389,105 | SEC↗ |
| HAIR Restoration Robotics Inc | J Other deriv | 2017-10-11 | 2017-10-13 | 0 | $1259269.79 | $0 | 0 | SEC↗ |
| NSTG NanoString Technologies In | A Award deriv | 2017-01-01 | 2017-01-04 | 8,611 | — | $0 | 8,611 | SEC↗ |
| RDUS Radius Health, Inc. | J Other | 2016-09-27 | 2016-09-29 | 1,229,902 | — | $0 | 2,459,804 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2016-08-03 | 2016-08-05 | 6,500 | — | $0 | 6,500 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-02-09 | 2016-02-10 | 230,507 | $0.16 | $36.9K | 2,214,523 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-02-08 | 2016-02-10 | 103,123 | $0.19 | $19.6K | 2,445,030 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-02-05 | 2016-02-05 | 832,881 | $0.20 | $166.6K | 2,548,153 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-02-04 | 2016-02-05 | 500,026 | $0.14 | $70.0K | 3,381,034 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-02-03 | 2016-02-05 | 82,583 | $0.15 | $12.4K | 3,881,060 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-02-02 | 2016-02-02 | 176,306 | $0.17 | $30.0K | 3,963,643 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-02-01 | 2016-02-02 | 140,000 | $0.20 | $28.0K | 4,139,949 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-01-29 | 2016-02-02 | 52,826 | $0.26 | $13.7K | 4,279,949 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-01-28 | 2016-01-28 | 32,521 | $0.26 | $8.5K | 4,332,775 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-01-27 | 2016-01-28 | 209,984 | $0.27 | $56.7K | 4,365,296 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | S Sale | 2016-01-26 | 2016-01-28 | 69,425 | $0.30 | $20.8K | 4,575,280 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2016-01-11 | 2016-01-13 | 999 | $65.45 | $65.4K | 6,685 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2016-01-11 | 2016-01-13 | 499 | $65.33 | $32.6K | 3,945 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2016-01-11 | 2016-01-13 | 501 | $65.45 | $32.8K | 4,444 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2016-01-11 | 2016-01-13 | 1,001 | $66.33 | $66.4K | 5,684 | SEC↗ |
| NSTG NanoString Technologies In | A Award deriv | 2016-01-01 | 2016-01-05 | 7,828 | — | $0 | 7,828 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2015-12-10 | 2015-12-14 | 733 | $64.63 | $47.4K | 4,945 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2015-12-10 | 2015-12-14 | 267 | $63.91 | $17.1K | 5,678 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2015-12-10 | 2015-12-14 | 1,467 | $64.63 | $94.8K | 7,684 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2015-12-10 | 2015-12-14 | 533 | $63.90 | $34.1K | 9,151 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2015-11-18 | 2015-11-19 | 1,000 | $60.00 | $60.0K | 9,684 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2015-11-18 | 2015-11-19 | 500 | $60.00 | $30.0K | 5,945 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2015-11-10 | 2015-11-12 | 1,000 | $58.69 | $58.7K | 10,684 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2015-11-10 | 2015-11-12 | 500 | $58.69 | $29.3K | 6,445 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2015-11-09 | 2015-11-12 | 1,000 | $60.00 | $60.0K | 11,684 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2015-11-09 | 2015-11-12 | 500 | $60.00 | $30.0K | 6,945 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2015-11-02 | 2015-11-04 | 500 | $54.00 | $27.0K | 7,445 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2015-11-02 | 2015-11-04 | 1,000 | $54.00 | $54.0K | 13,184 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2015-06-30 | 2015-06-30 | 11,094 | — | $0 | 11,094 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion deriv | 2015-06-30 | 2015-06-30 | 9,728,971 | — | $0 | 0 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion deriv | 2015-06-30 | 2015-06-30 | 20,800,000 | — | $0 | 0 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | P Buy | 2015-06-30 | 2015-06-30 | 376,695 | $12.00 | $4.52M | 2,752,488 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion | 2015-06-30 | 2015-06-30 | 757,117 | — | $0 | 2,375,793 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion | 2015-06-30 | 2015-06-30 | 1,618,676 | — | $0 | 1,618,676 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-16 | 2015-06-17 | 39,701 | $14.30 | $567.7K | 2,237,377 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-15 | 2015-06-17 | 1,529 | $14.27 | $21.8K | 2,277,078 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-12 | 2015-06-12 | 6,430 | $14.25 | $91.6K | 2,278,607 | SEC↗ |
| OPHT Ophthotech Corp. | G Gift | 2015-06-12 | 2015-06-29 | 1,020 | — | $0 | 14,184 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-11 | 2015-06-12 | 25,168 | $14.27 | $359.1K | 2,285,037 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-10 | 2015-06-10 | 8,987 | $14.32 | $128.7K | 2,310,205 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-09 | 2015-06-10 | 13,000 | $14.26 | $185.4K | 2,319,192 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-08 | 2015-06-10 | 2,662 | $14.25 | $37.9K | 2,332,192 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2015-06-04 | 2015-06-08 | 1,750 | — | $0 | 1,750 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2015-06-04 | 2015-06-08 | 7,000 | — | $0 | 7,000 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-03 | 2015-06-03 | 10,450 | $14.32 | $149.6K | 2,334,854 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-02 | 2015-06-03 | 11,014 | $14.25 | $156.9K | 2,345,304 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-06-01 | 2015-06-03 | 15,010 | $14.29 | $214.5K | 2,356,318 | SEC↗ |
| OPHT Ophthotech Corp. | J Other | 2015-05-26 | 2015-05-28 | 7,319 | — | $0 | 15,204 | SEC↗ |
| OPHT Ophthotech Corp. | J Other | 2015-05-26 | 2015-05-28 | 3,137 | — | $0 | 7,945 | SEC↗ |
| OPHT Ophthotech Corp. | J Other | 2015-05-26 | 2015-05-28 | 1,554,744 | — | $0 | 0 | SEC↗ |
| OPHT Ophthotech Corp. | J Other | 2015-05-26 | 2015-05-28 | 1,554,744 | — | $0 | 0 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-03-23 | 2015-03-24 | 26,300 | $14.44 | $379.8K | 2,371,328 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-03-20 | 2015-03-24 | 27,115 | $14.53 | $394.0K | 2,397,628 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-03-19 | 2015-03-19 | 50,012 | $14.61 | $730.7K | 2,424,743 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-03-18 | 2015-03-19 | 25,000 | $14.68 | $367.0K | 2,474,755 | SEC↗ |
| OXFD Oxford Immunotec Global PL | S Sale | 2015-03-17 | 2015-03-19 | 79,307 | $14.67 | $1.16M | 2,499,755 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | J Other | 2015-01-28 | 2015-01-30 | 3,139,447 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2015-01-08 | 2015-01-12 | 175,000 | $31.11 | $5.44M | 3,324,259 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2015-01-05 | 2015-01-06 | 10,200 | $31.11 | $317.3K | 3,499,259 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2015-01-05 | 2015-01-06 | 13,420 | $30.67 | $411.6K | 3,509,459 | SEC↗ |
| NSTG NanoString Technologies In | A Award deriv | 2015-01-01 | 2015-01-05 | 7,307 | — | $0 | 7,307 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2014-12-29 | 2014-12-30 | 6,214 | $30.03 | $186.6K | 3,522,879 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2014-12-26 | 2014-12-30 | 74,510 | $30.05 | $2.24M | 3,529,093 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2014-12-23 | 2014-12-24 | 263 | $30.00 | $7.9K | 3,603,603 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2014-12-22 | 2014-12-24 | 49,441 | $30.36 | $1.50M | 3,603,866 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2014-06-27 | 2014-07-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2014-06-16 | 2014-06-16 | 15,482 | $44.00 | $681.2K | 2,698,588 | SEC↗ |
| OPHT Ophthotech Corp. | J Other | 2014-06-16 | 2014-06-18 | 5,385 | $44.24 | $238.2K | 7,885 | SEC↗ |
| OPHT Ophthotech Corp. | J Other | 2014-06-16 | 2014-06-18 | 2,308 | $44.24 | $102.1K | 4,808 | SEC↗ |
| OPHT Ophthotech Corp. | J Other | 2014-06-16 | 2014-06-18 | 1,143,844 | $44.24 | $50.60M | 1,554,744 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2014-06-13 | 2014-06-16 | 82,277 | $44.01 | $3.62M | 2,714,070 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2014-06-12 | 2014-06-16 | 47,217 | $44.51 | $2.10M | 2,796,347 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | A Award deriv | 2014-06-11 | 2014-06-16 | 13,500 | — | $0 | 13,500 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2014-06-11 | 2014-06-11 | 29,217 | $44.53 | $1.30M | 2,843,564 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2014-06-11 | 2014-06-11 | 500 | $44.32 | $22.2K | 4,500 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2014-06-10 | 2014-06-11 | 404 | $23.36 | $9.4K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2014-06-10 | 2014-06-11 | 965 | $23.36 | $22.5K | 0 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2014-06-10 | 2014-06-11 | 79,824 | $44.66 | $3.56M | 2,909,861 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2014-06-10 | 2014-06-11 | 36,880 | $45.90 | $1.69M | 2,872,981 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2014-06-10 | 2014-06-11 | 200 | $46.80 | $9.4K | 2,872,781 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2014-06-09 | 2014-06-11 | 25,697 | $46.02 | $1.18M | 3,029,047 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2014-06-09 | 2014-06-11 | 39,362 | $46.78 | $1.84M | 2,989,685 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion deriv | 2014-06-06 | 2014-06-10 | 269,724 | — | $0 | 0 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion deriv | 2014-06-06 | 2014-06-10 | 91,175 | — | $0 | 0 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion deriv | 2014-06-06 | 2014-06-10 | 53,331 | — | $0 | 0 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion deriv | 2014-06-06 | 2014-06-10 | 217,873 | — | $0 | 0 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion | 2014-06-06 | 2014-06-10 | 1,045,351 | — | $0 | 2,339,485 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion | 2014-06-06 | 2014-06-10 | 1,294,134 | — | $0 | 1,294,134 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion | 2014-06-06 | 2014-06-10 | 255,881 | — | $0 | 2,595,366 | SEC↗ |
| RDUS Radius Health, Inc. | C Conversion | 2014-06-06 | 2014-06-10 | 399,891 | — | $0 | 2,995,257 | SEC↗ |
| RDUS Radius Health, Inc. | J Other | 2014-06-06 | 2014-06-10 | 694,449 | — | $0 | 3,689,706 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2014-05-21 | 2014-05-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | J Other | 2014-02-26 | 2014-03-27 | 404 | — | $0 | 404 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | J Other | 2014-02-26 | 2014-03-27 | 965 | — | $0 | 965 | SEC↗ |
| NSTG NanoString Technologies In | A Award deriv | 2014-01-01 | 2014-01-03 | 5,847 | — | $0 | 5,847 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-19 | 853,416 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | X Exercise deriv | 2013-12-17 | 2013-12-19 | 23,282 | $6.40 | $149.0K | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-19 | 2,342,944 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | X Exercise | 2013-12-17 | 2013-12-19 | 23,282 | $6.40 | $149.0K | 4,644,705 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | P Buy | 2013-12-17 | 2013-12-19 | 1,425,063 | $7.00 | $9.98M | 1,425,063 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-19 | 853,416 | $7.00 | $5.97M | 4,621,423 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-19 | 2,342,944 | — | $0 | 3,768,007 | SEC↗ |
| OXFD Oxford Immunotec Global PL | C Conversion deriv | 2013-11-22 | 2013-11-25 | 203,439 | — | $0 | 0 | SEC↗ |
| OXFD Oxford Immunotec Global PL | C Conversion deriv | 2013-11-22 | 2013-11-25 | 553,859 | — | $0 | 0 | SEC↗ |
| OXFD Oxford Immunotec Global PL | C Conversion deriv | 2013-11-22 | 2013-11-25 | 1,239,308 | — | $0 | 0 | SEC↗ |
| OXFD Oxford Immunotec Global PL | C Conversion deriv | 2013-11-22 | 2013-11-25 | 582,456 | — | $0 | 0 | SEC↗ |
| OXFD Oxford Immunotec Global PL | C Conversion | 2013-11-22 | 2013-11-25 | 582,456 | — | $0 | 582,456 | SEC↗ |
| OXFD Oxford Immunotec Global PL | C Conversion | 2013-11-22 | 2013-11-25 | 1,239,308 | — | $0 | 1,821,764 | SEC↗ |
| OXFD Oxford Immunotec Global PL | C Conversion | 2013-11-22 | 2013-11-25 | 553,859 | — | $0 | 2,375,623 | SEC↗ |
| OXFD Oxford Immunotec Global PL | C Conversion | 2013-11-22 | 2013-11-25 | 203,439 | — | $0 | 2,579,062 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2015-01-30 | 184,812 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2015-01-30 | 184,812 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2013-10-25 | 2015-01-30 | 321,000 | $10.00 | $3.21M | 3,468,494 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2013-10-28 | 420,222 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2013-10-28 | 2,727,272 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion deriv | 2013-10-25 | 2013-10-28 | 184,812 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion | 2013-10-25 | 2013-10-28 | 420,222 | — | $0 | 3,147,494 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion | 2013-10-25 | 2013-10-28 | 184,812 | $0.05 | $9.2K | 3,332,306 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2013-10-25 | 2013-10-28 | 321,000 | $10.00 | $3.21M | 3,653,306 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | C Conversion | 2013-10-25 | 2013-10-28 | 2,727,272 | — | $0 | 2,727,272 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2013-10-23 | 2013-10-25 | 22,033 | — | $0 | 22,033 | SEC↗ |
| OPHT Ophthotech Corp. | C Conversion deriv | 2013-09-30 | 2013-10-02 | 2,542,373 | — | $0 | 0 | SEC↗ |
| OPHT Ophthotech Corp. | C Conversion deriv | 2013-09-30 | 2013-10-02 | 186,027 | — | $0 | 0 | SEC↗ |
| OPHT Ophthotech Corp. | C Conversion | 2013-09-30 | 2013-10-02 | 186,027 | — | $0 | 2,728,390 | SEC↗ |
| OPHT Ophthotech Corp. | C Conversion | 2013-09-30 | 2013-10-02 | 2,542,373 | — | $0 | 2,542,373 | SEC↗ |
| OPHT Ophthotech Corp. | P Buy | 2013-09-30 | 2013-11-20 | 2,500 | $22.00 | $55.0K | 2,500 | SEC↗ |
| OPHT Ophthotech Corp. | P Buy | 2013-09-30 | 2013-11-20 | 2,500 | $22.00 | $55.0K | 2,500 | SEC↗ |
| GMED GLOBUS MEDICAL INC | J Other | 2013-09-03 | 2013-09-04 | 7,244,201 | — | $0 | 0 | SEC↗ |
| NSTG NanoString Technologies In | A Award deriv | 2013-07-10 | 2013-07-12 | 8,768 | — | $0 | 8,768 | SEC↗ |
| NSTG NanoString Technologies In | C Conversion deriv | 2013-07-01 | 2013-07-01 | 148,342 | — | $0 | 0 | SEC↗ |
| NSTG NanoString Technologies In | C Conversion deriv | 2013-07-01 | 2013-07-01 | 162,408 | $8.45 | $1.37M | 0 | SEC↗ |
| NSTG NanoString Technologies In | C Conversion deriv | 2013-07-01 | 2013-07-01 | 162,408 | $8.45 | $1.37M | 162,408 | SEC↗ |
| NSTG NanoString Technologies In | C Conversion deriv | 2013-07-01 | 2013-07-01 | 812,045 | — | $0 | 0 | SEC↗ |
| NSTG NanoString Technologies In | C Conversion deriv | 2013-07-01 | 2013-07-01 | 2,249,053 | — | $0 | 0 | SEC↗ |
| NSTG NanoString Technologies In | C Conversion | 2013-07-01 | 2013-07-01 | 812,045 | — | $0 | 3,061,098 | SEC↗ |
| NSTG NanoString Technologies In | C Conversion | 2013-07-01 | 2013-07-01 | 148,342 | — | $0 | 3,209,440 | SEC↗ |
| NSTG NanoString Technologies In | A Award | 2013-07-01 | 2013-07-01 | 750,000 | $10.00 | $7.50M | 3,959,440 | SEC↗ |
| NSTG NanoString Technologies In | C Conversion | 2013-07-01 | 2013-07-01 | 2,249,053 | — | $0 | 2,249,053 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2013-06-05 | 2013-06-07 | 14,101 | — | $0 | 14,101 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 54,323 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 24,400 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 68,280 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 15,642 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 120,566 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 8,106 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 3,641 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 10,189 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 2,334 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 550,530 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 37,016 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 16,625 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 46,526 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 10,658 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 553,204 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 37,196 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 16,707 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 46,752 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 10,710 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 807,939 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion | 2013-05-28 | 2013-05-30 | 39,344 | — | $0 | 39,344 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion | 2013-05-28 | 2013-05-30 | 171,747 | — | $0 | 171,747 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion | 2013-05-28 | 2013-05-30 | 61,373 | — | $0 | 61,373 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion | 2013-05-28 | 2013-05-30 | 136,641 | — | $0 | 136,641 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion | 2013-05-28 | 2013-05-30 | 2,032,239 | — | $0 | 2,032,239 | SEC↗ |
| RDUS Radius Health, Inc. | P Buy deriv | 2013-04-23 | 2013-04-30 | 91,175 | $61.42 | $5.60M | 0 | SEC↗ |
| RDUS Radius Health, Inc. | P Buy deriv | 2013-04-23 | 2013-04-30 | 227,939 | $6.14 | $1.40M | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 1,949,879 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 275,539 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion deriv | 2013-02-05 | 2013-02-07 | 337,622 | — | $0 | 0 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 1,949,879 | — | $0 | 1,949,879 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 313,527 | — | $0 | 2,632,928 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | C Conversion | 2013-02-05 | 2013-02-07 | 369,522 | — | $0 | 2,319,401 | SEC↗ |
| GMED GLOBUS MEDICAL INC | C Conversion deriv | 2012-08-08 | 2012-08-10 | 7,444,168 | — | $0 | 0 | SEC↗ |
| GMED GLOBUS MEDICAL INC | S Sale | 2012-08-08 | 2012-08-10 | 804,232 | $11.16 | $8.98M | 7,244,201 | SEC↗ |
| GMED GLOBUS MEDICAL INC | C Conversion | 2012-08-08 | 2012-08-10 | 7,444,168 | — | $0 | 8,048,433 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-07-09 | 2012-07-10 | 1,624,574 | $0.31 | $503.6K | 1,275,886 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-07-06 | 2012-07-10 | 671,217 | $0.29 | $194.7K | 2,900,460 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-07-03 | 2012-07-05 | 98,210 | $0.29 | $28.5K | 3,571,677 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-07-02 | 2012-07-05 | 80,348 | $0.29 | $23.3K | 3,669,887 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-06-28 | 2012-07-02 | 19,500 | $0.29 | $5.7K | 3,750,235 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-06-19 | 2012-06-21 | 12,000 | $0.29 | $3.5K | 3,759,735 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-06-15 | 2012-06-19 | 1,450 | $0.29 | $420 | 3,781,735 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-06-06 | 2012-06-07 | 8,400 | $0.29 | $2.4K | 3,783,185 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-06-05 | 2012-06-07 | 29,555 | $0.29 | $8.6K | 3,791,585 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | J Other | 2012-06-04 | 2012-06-06 | 10,942,468 | — | $0 | 3 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | X Exercise deriv | 2012-05-31 | 2012-06-04 | 1,290,922 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | X Exercise deriv | 2012-05-31 | 2012-06-04 | 1,706,426 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | X Exercise | 2012-05-31 | 2012-06-04 | 1,290,922 | $3.53 | $4.56M | 10,553,001 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2012-05-31 | 2012-06-04 | 708,810 | $7.49 | $5.31M | 10,942,471 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | X Exercise | 2012-05-31 | 2012-06-04 | 1,706,426 | $3.11 | $5.31M | 12,259,427 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2012-05-31 | 2012-06-04 | 608,146 | $7.49 | $4.56M | 11,651,281 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-05-31 | 2012-06-04 | 29,850 | $0.30 | $9.0K | 3,821,140 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-05-30 | 2012-06-04 | 51,007 | $0.30 | $15.3K | 3,850,990 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-05-29 | 2012-06-04 | 15,300 | $0.30 | $4.6K | 3,901,997 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-05-25 | 2012-06-04 | 293,015 | $0.30 | $87.9K | 3,917,297 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-05-23 | 2012-06-04 | 135,250 | $0.30 | $40.6K | 4,210,312 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-05-22 | 2012-06-04 | 287,000 | $0.30 | $86.1K | 4,345,562 | SEC↗ |